The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 27, 2022
Filed:
Jun. 26, 2020
Applicant:
Alkermes Pharma Ireland Limited, Dublin, IE;
Inventors:
Laura Cook Blumberg, Lincoln, MA (US);
Daniel R. Deaver, Franklin, MA (US);
David J. Eyerman, Wayland, MA (US);
Thomas Andrew Wynn, Lexington, MA (US);
Assignee:
ALKERMES PHARMA IRELAND LIMITED, Dublin, IE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/485 (2006.01); C07D 211/62 (2006.01); C07D 217/04 (2006.01); C07D 221/22 (2006.01); C07D 221/28 (2006.01); C07D 223/04 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 489/00 (2006.01); C07D 489/09 (2006.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); C07D 211/62 (2013.01); C07D 217/04 (2013.01); C07D 221/22 (2013.01); C07D 221/28 (2013.01); C07D 223/04 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 489/00 (2013.01); C07D 489/09 (2013.01);
Abstract
The present application relates methods for treating a depressive symptom comprising administering an effective amount of a μ opioid receptor agonist or a pharmaceutically acceptable salt thereof to a subject in need thereof. Non-limiting examples of such agonist include the compounds of Formulas I, II, III, and IV, as well as the compounds of Table A.